Note: Ingredients listed on restricted chemical lists
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
N/A
EC/CAS
9003-11-6
Name of the chemical
poly(ethylene propylene) glycol
Concentration
N/A
EC/CAS
25655-41-8
Name of the chemical
Polyvinylpyrrolidone iodine
Concentration
N/A
General Information
Revision date
2023-06-17
Product name
Deferasirox Oral Granules 90 mg, 180 mg and 360 mg
1.2.1 Relevant identified uses
by multiple blood transfusions
Manufacturer Name
Annora Pharma Private Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Skin Corrosion/Irritation, Category 2 Serious Eye Damage/Eye Irritation, Category 2 Specific Target Organ Toxicity (single exposure), Category 3 Aquatic Toxicity (Chronic), Category 1
Potential health effects
Causes serious eye irritation. Causes skin irritation. Material may be irritating to the mucous membranes and upper respiratory tract. May be harmful by inhalation, ingestion, or skin absorption. May cause respiratory system irritation.